Global Cardiovascular Therapeutics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	219 Pages	TechNavio	March, 2025	INF19892318

Best Price Guarantee
Price	from $2,500
Length	219 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19892318

Cardiovascular Therapeutics Market 2025-2029

The cardiovascular therapeutics market is forecasted to grow by USD 25.32 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, availability of advanced diagnostic methods, and rising prevalence of hypercholesterolemia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cardiovascular therapeutics market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail Pharmacy
Online pharmacy

By Type

Antithrombotic drugs
Hypolipidemic drugs
Others

By Route Of Administration

Oral
Injectable
Transdermal

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the advent of novel oral anticoagulants (NOACs) as one of the prime reasons driving the cardiovascular therapeutics market growth during the next few years. Also, identification of new pathogenic targets related to cardiovascular diseases and strong incidence of coronary heart disease (CHD) worldwide will lead to sizable demand in the market.

The report on the cardiovascular therapeutics market covers the following areas:

Cardiovascular Therapeutics Market sizing
Cardiovascular Therapeutics Market forecast
Cardiovascular Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiovascular therapeutics market vendors that include Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., DR Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the cardiovascular therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Data Table on Incremental Growth
Technavio Analysis
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Criticality of inputs and Factors of differentiation
- Factors of disruption
- Impact of drivers and challenges
Market Landscape
- Market ecosystem
  - Table Data Table on - Parent Market
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2024
- Market outlook: Forecast for 2024-2029
  - Table Data Table on Global - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Historic Market Size
- Global Cardiovascular Therapeutics Market 2019 - 2023
  - Table Historic Market Size - Data Table on Global Cardiovascular Therapeutics Market 2019 - 2023 ($ million)
- Distribution Channel segment analysis 2019 - 2023
- Type segment analysis 2019 - 2023
- Route of Administration segment analysis 2019 - 2023
- Geography segment analysis 2019 - 2023
- Country segment analysis 2019 - 2023
Qualitative Analysis
- The AI impact on Global Cardiovascular Therapeutics Market
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Distribution Channel
- Market segments
  - Table Data Table on Distribution Channel - Market share 2024-2029 (%)
- Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacy - Market size and forecast 2024-2029
  - Table Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Retail Pharmacy - Market size and forecast 2024-2029
  - Table Data Table on Retail Pharmacy - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Retail Pharmacy - Year-over-year growth 2024-2029 (%)
- Online pharmacy - Market size and forecast 2024-2029
  - Table Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Market opportunity by Distribution Channel
  - Table Data Table on Market opportunity by Distribution Channel ($ million)
Market Segmentation by Type
- Market segments
  - Table Data Table on Type - Market share 2024-2029 (%)
- Comparison by Type
  - Table Data Table on Comparison by Type
- Antithrombotic drugs - Market size and forecast 2024-2029
  - Table Data Table on Antithrombotic drugs - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Antithrombotic drugs - Year-over-year growth 2024-2029 (%)
- Hypolipidemic drugs - Market size and forecast 2024-2029
  - Table Data Table on Hypolipidemic drugs - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Hypolipidemic drugs - Year-over-year growth 2024-2029 (%)
- Others - Market size and forecast 2024-2029
  - Table Data Table on Others - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type
  - Table Data Table on Market opportunity by Type ($ million)
Market Segmentation by Route of Administration
- Market segments
  - Table Data Table on Route of Administration - Market share 2024-2029 (%)
- Comparison by Route of Administration
  - Table Data Table on Comparison by Route of Administration
- Oral - Market size and forecast 2024-2029
  - Table Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Oral - Year-over-year growth 2024-2029 (%)
- Injectable - Market size and forecast 2024-2029
  - Table Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Injectable - Year-over-year growth 2024-2029 (%)
- Transdermal - Market size and forecast 2024-2029
  - Table Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
- Market opportunity by Route of Administration
  - Table Data Table on Market opportunity by Route of Administration ($ million)
Customer Landscape
- Customer landscape overview
Geographic Landscape
- Geographic segmentation
  - Table Data Table on Market share by geography 2024-2029 (%)
- Geographic comparison
  - Table Data Table on Geographic comparison
- Asia - Market size and forecast 2024-2029
  - Table Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Asia - Year-over-year growth 2024-2029 (%)
- North America - Market size and forecast 2024-2029
  - Table Data Table on North America - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on North America - Year-over-year growth 2024-2029 (%)
- Europe - Market size and forecast 2024-2029
  - Table Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Rest of World (ROW) - Market size and forecast 2024-2029
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- US - Market size and forecast 2024-2029
  - Table Data Table on US - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on US - Year-over-year growth 2024-2029 (%)
- China - Market size and forecast 2024-2029
  - Table Data Table on China - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on China - Year-over-year growth 2024-2029 (%)
- Japan - Market size and forecast 2024-2029
  - Table Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Japan - Year-over-year growth 2024-2029 (%)
- India - Market size and forecast 2024-2029
  - Table Data Table on India - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on India - Year-over-year growth 2024-2029 (%)
- South Korea - Market size and forecast 2024-2029
  - Table Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Canada - Market size and forecast 2024-2029
  - Table Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Canada - Year-over-year growth 2024-2029 (%)
- UK - Market size and forecast 2024-2029
  - Table Data Table on UK - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on UK - Year-over-year growth 2024-2029 (%)
- Germany - Market size and forecast 2024-2029
  - Table Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Germany - Year-over-year growth 2024-2029 (%)
- France - Market size and forecast 2024-2029
  - Table Data Table on France - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on France - Year-over-year growth 2024-2029 (%)
- Italy - Market size and forecast 2024-2029
  - Table Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Opportunity/Restraints
- Market drivers
  - Increasing risk factors for cardiovascular diseases
  - Availability of advanced diagnostic methods
  - Rising prevalence of hypercholesterolemia
- Market challenges
  - Advent of wearable defibrillators
  - Side effects associated with cardiovascular therapeutics
  - Product recalls
- Impact of drivers and challenges
- Market opportunities/restraints
  - Advent of novel oral anticoagulants (NOACs)
  - Identification of new pathogenic targets related to cardiovascular diseases
  - Strong incidence of coronary heart disease (CHD) worldwide
Competitive Landscape
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
Competitive Analysis
- Companies profiled
- Company ranking index
- Market positioning of companies
- Abbott Laboratories
- Astellas Pharma Inc.
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Viatris Inc.
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations